Akoya Biosciences, Inc. (AKYA) Q3 2022 Earnings Call Transcript

Nov. 07, 2022 8:04 PM ETAkoya Biosciences, Inc. (AKYA)
SA Transcripts profile picture
SA Transcripts

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET

Company Participants

Priyam Shah - Senior Director, Investor Relations

Brian McKelligon - Chief Executive Officer

Joseph Driscoll - Chief Financial Officer

Conference Call Participants

Mason Carrico - Stephens

Mark Massaro - BTIG

Neil Vibhakar - Morgan Stanley


Good day and thank you for standing by. Welcome to the Akoya Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] please be advised that today's conference is being recorded.

I'd now like to hand the conference over to your speaker today, Priyam Shah, Head of Investor Relations.

Priyam Shah

Thank you, operator and thank you everyone who is joining us today on this call. I'm Priyam Shah, Head of Investor Relations at Akoya Biosciences.

On the call today, we have Brian McKelligon, Chief Executive Officer; and Joe Driscoll, Chief Financial Officer. Earlier today, Akoya released financial results for the third quarter ended September 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Akoya's business, please refer to the Risk Factors section of our Form 10-K filed with the Securities and

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.